Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

γδT Cells and CD1d, Novel Immune Players in Alcoholic and Nonalcoholic Steatohepatitis?

Wang X, Gao B.

Hepatology. 2019 Nov 7. doi: 10.1002/hep.31025. [Epub ahead of print] No abstract available.

PMID:
31698503
2.

The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner.

Li F, Hao X, Chen Y, Bai L, Gao X, Lian Z, Wei H, Sun R, Tian Z.

Nat Commun. 2017 Jan 9;7:13839. doi: 10.1038/ncomms13839.

3.

Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.

Piazza NA, Singal AK.

Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17.

4.

[The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis].

Zamin JI, de Mattos AA, Perin C, Ramos GZ.

Arq Gastroenterol. 2002 Jan-Mar;39(1):22-6. Portuguese.

PMID:
12184161
5.

Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.

Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ.

Cell Mol Gastroenterol Hepatol. 2015 Jun 3;1(4):356-367. doi: 10.1016/j.jcmgh.2015.05.006. eCollection 2015 Jul. Review.

6.

The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.

Sutti S, Bruzzì S, Albano E.

Expert Rev Gastroenterol Hepatol. 2016;10(2):243-53. doi: 10.1586/17474124.2016.1111758. Epub 2015 Dec 3. Review.

PMID:
26634783
7.

Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease.

Byun JS, Yi HS.

Biomed Res Int. 2017;2017:6862439. doi: 10.1155/2017/6862439. Epub 2017 Aug 9. Review.

9.

[Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].

Spahr L, Rubbia-Brandt L, Hadengue A.

Rev Med Suisse. 2005 Sep 7;1(31):2026-8, 2030-1. Review. French.

PMID:
16212004
10.

Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.

Kishida N, Matsuda S, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Hibi T, Masugi Y, Aiura K, Sakamoto M, Kitagawa Y.

BMC Gastroenterol. 2016 Jun 13;16(1):61. doi: 10.1186/s12876-016-0477-5.

11.

Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis.

Fletcher LM, Kwoh-Gain I, Powell EE, Powell LW, Halliday JW.

Hepatology. 1991 Mar;13(3):455-9.

PMID:
1999316
12.

Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.

Quillin RC 3rd, Wilson GC, Sutton JM, Hanseman DJ, Paterno F, Cuffy MC, Paquette IM, Diwan TS, Woodle ES, Abbott DE, Shah SA.

Surgery. 2014 Oct;156(4):1049-56. doi: 10.1016/j.surg.2014.06.075.

PMID:
25239365
13.

Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?

Sundaram V, Morgan TR.

Clin Liver Dis. 2019 Feb;23(1):157-165. doi: 10.1016/j.cld.2018.09.008. Review.

PMID:
30454829
14.
15.

Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.

Mendel I, Yacov N, Shoham A, Ishai E, Breitbart E.

Dig Dis Sci. 2016 Sep;61(9):2545-53. doi: 10.1007/s10620-016-4159-5. Epub 2016 Apr 13.

16.

Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?

Sakhuja P.

World J Gastroenterol. 2014 Nov 28;20(44):16474-9. doi: 10.3748/wjg.v20.i44.16474. Review.

17.

Clinical and pathogenetic features of nonalcoholic steatohepatitis for comorbidity with bronchial asthma on the background of obesity.

Khukhlina OS, Antoniv AA, Mandryk OY, Hryniuk OY, Kovalenko SV, Drozd VY, Kotsiubiichuk ZI.

Wiad Lek. 2018;71(2 pt 1):376-379.

PMID:
29729177
18.

Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

Laho T, Clarke JD, Dzierlenga AL, Li H, Klein DM, Goedken M, Micuda S, Cherrington NJ.

Biochem Pharmacol. 2016 Sep 1;115:144-51. doi: 10.1016/j.bcp.2016.07.001. Epub 2016 Jul 2.

19.

Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.

Polanco-Briceno S, Glass D, Stuntz M, Caze A.

BMC Res Notes. 2016 Mar 11;9:157. doi: 10.1186/s13104-016-1946-1.

20.

INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS.

Leghi GE, Domenici FA, Vannucchi H.

Arq Gastroenterol. 2015 Jul-Sep;52(3):228-33. doi: 10.1590/S0004-28032015000300014.

Supplemental Content

Support Center